Drugability Challenges

Alex discusses the complexities of drugging challenging targets, like the oncogene C myc, emphasizing the importance of understanding protein structure and interactions. He highlights the need for a strategic balance between confidence, novelty, and commercial viability when selecting drug targets, as well as the critical timing in development to avoid running out of resources.